Abstract:Background: Acute kidney injury (AKI) is one of the most important causes of mortality and morbidity worldwide. Mesenchymal stem cells (MSCs) can be used for stem cell-based therapy containing AKI. Magnetic resonance imaging (MRI) is an ideal mean for stem cells tracking by labeling with superparamagnetic iron oxide (SPIO). Therefore, using the iron oxide-labeled mesenchymal stem cells (MSC) to treat the AKI and evaluating migration, distribution, and homing of cells by MRI is an ideal method for cell therapy and cell tracking in vivo. Methods: In vitro, the MSCs were labeled with 25 μg/mL for 24 h, and test the labeled efficiency and cells viability. In vitro experiments, magnetic resonance imaging (MRI) measurement of non-labeled and SPIO-labeled MSCs (SPIO-MSCs) was performed in correlation to detectable cells concentrations and detectable time windows. In vivo experiments, MRI evaluation was performed before and after ischemic/reperfusion AKI (N = 14) and intravenous injection of 5 × 10(5) SPIO-MSCs (N = 10), PBS (N = 6) up to 8 days using a clinical 1.5 T scanner. Signal intensity of kidneys were measured and tested for statistical significance (unpaired Student's t-test, p < 0.05) in comparison histology (hematoxylin and eosin [H&E], Prussian blue). Results: In vitro, MSCs can be labeled with the SPIO without affecting the viability and labeling efficiency. SPIO-MSCs showed a reduction of signal intensity at T2WI and T2*WI, 5 × 10(4) cells/mL, SPIO-MSCs were the minimum imaging cells concentration using a 1.5 T MR in vitro. In vivo, SPIO-MSCs administration resulted in a T2*WI signal intensity decrease in renal medulla caused by SPIO-MSCs accumulation in contrast to control groups (p < 0.05) up to day 3 after transplantation, but T2*WI low signal intensity region of the renal medulla revealed an decrease at day 5, and no significant differences between SPIO-MSCs and control animals at day 8. Conclusion: Our data demonstrate that in vitro and in vivo, cell-tracking and monitoring of kidney distribution of intravenous injected SPIO-MSCs after AKI is feasible in MRI at 1.5 T.

The Application of Super Paramagnetic Iron Oxide-Labeled Mesenchymal Stem Cells in Cell-Based Therapy

Labeling Neural Stem Cells with Superparamagnetic Iron Oxide and MRI Tracking in Vitro and in Vivo

Stem Cell Labeling With Superparamagnetic Iron Oxide Nanoparticles Using Focused Ultrasound And Magnetic Resonance Imaging Tracking

Biological activity and magnetic resonance imaging of superparamagnetic iron oxide nanoparticles-labeled adipose-derived stem cells

Assessment of Biological Characteristics of Mesenchymal Stem Cells Labeled with Superparamagnetic Iron Oxide Particles in Vitro.

Labeling mesenchymal stem cells in the heart with superparamagnetic iron oxide nanoparticles in vitro and tracking after implantation with MRI in vivo

Extracellular Magnetic Labeling of Biomimetic Hydrogel-Induced Human Mesenchymal Stem Cell Spheroids with Ferumoxytol for MRI Tracking

Tracking mesenchymal stem cells using magnetic resonance imaging

Labeling of Cynomolgus Monkey Bone Marrow-Derived Mesenchymal Stem Cells for Cell Tracking by Multimodality Imaging.

Superparamagnetic Iron Oxide Nanoparticles As MRI Contrast Agents for Non-invasive Stem Cell Labeling and Tracking

Superparamagnetic Iron Oxide Nanoparticles-Complexed Cationic Amylose for In Vivo Magnetic Resonance Imaging Tracking of Transplanted Stem Cells in Stroke

In Vitro Labeling of Human Umbilical Cord Mesenchymal Stem Cells with Superparamagnetic Iron Oxide Nanoparticles

Low molecular weight alkyl-polycation wrapped magnetite nanoparticle clusters as MRI probes for stem cell labeling and in vivo imaging.

Biocompatible Iron Oxide Nanoring-Labeled Mesenchymal Stem Cells: An Innovative Magnetothermal Approach for Cell Tracking and Targeted Stroke Therapy

Magnetic Resonance Tracking of Transplanted Neural Stem Cells Labeled with Superparamagnetic Iron Oxides in APP/PS1 Transgenic Mice

Optimal technique for canine mesenchymal stem cells labeling with novel SPIO, MIRBTM: for MRI detection of transplanted stem cells canine stroke model

In vivo magnetic resonance imaging of iron oxide-labeled, intravenous-injected mesenchymal stem cells in kidneys of rabbits with acute ischemic kidney injury: detection and monitoring at 1.5 T

Stem cell tracking using effective self-assembled peptide-modified superparamagnetic nanoparticles.

In Vivo Mri Tracking of Iron Oxide Nanoparticle-Labeled Human Mesenchymal Stem Cells in Limb Ischemia

Magnetic Nanoparticles for Labelling and Functional Regulation of Mesenchymal Stem Cells

In Vivo Tracking of Superparamagnetic Iron Oxide Nanoparticle-Labeled Mesenchymal Stem Cell Tropism to Malignant Gliomas Using Magnetic Resonance Imaging. Laboratory Investigation.